SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Vaccines

PUBLISHER: Grand View Research | PRODUCT CODE: 2132436

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132436

BCG Vaccine Market Size, Share & Trends Analysis Report By Product, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

BCG Vaccine Market Summary

The global BCG vaccine market size was valued at USD 181.8 million in 2025 and is projected to grow from USD 190.3 million in 2026 to USD 275.5 million by 2033, at a CAGR of 5.4% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest share of 47.8% in 2025. The industry is supported by the continued use of the Bacillus Calmette-Guerin (BCG) vaccine for tuberculosis (TB) prevention and the treatment of non-muscle invasive bladder cancer.

The vaccine is included in national immunization programs in many countries with a moderate to high TB burden, especially across Asia Pacific, Africa, and parts of Latin America. Government vaccination programs and procurement by public health agencies continue to support market demand. The market has a limited number of manufacturers, making supply dependent on production capacity, regulatory compliance, and quality standards. Manufacturers are investing in production upgrades and capacity expansion to improve product availability. Research on new therapeutic uses of BCG is ongoing, but its primary use remains TB prevention and bladder cancer treatment. Support from global health organizations, continued focus on tuberculosis control, and stable demand from public healthcare systems continue to maintain the market across developed and developing countries.

Global BCG Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global BCG vaccine market report based on product, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune BCG Vaccine
  • Therapeutic BCG Vaccine
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Public Sector
  • Private Sector
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-173-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. BCG Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. BCG Vaccine Market: Product Business Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Immune BCG Vaccine
    • 4.4.1. Immune BCG Vaccine Market, 2021 - 2033 (USD Million)
  • 4.5. Therapeutic BCG Vaccine
    • 4.5.1. Therapeutic BCG Vaccine Market, 2021 - 2033 (USD Million)

Chapter 5. BCG Vaccine Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2025 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Public Sector
    • 5.4.1. Public Sector Market, 2021 - 2033 (USD Million)
  • 5.5. Private Sector
    • 5.5.1. Private Sector Market, 2021 - 2033 (USD Million)

Chapter 6. BCG Vaccine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America BCG Vaccine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. Canada BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. UK BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Brazil BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. Argentina BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Merck & Co., Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Serum Institute of India Pvt. Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Japan BCG Laboratory
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AJ Vaccines A/S
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. China National Biotec Group (CNBG)
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. GreenSignal Bio Pharma Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. InterVax Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. BioFarma.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Biomed-Lublin S.A.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BB-NCIPD Ltd.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-173-3

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global BCG vaccine market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 6 North America BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 10 U.S. BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe BCG vaccine market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 19 UK BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 22 France BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 23 France BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 25 Italy BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 27 Spain BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 29 Norway BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 31 Denmark BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 33 Sweden BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 38 Japan BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 39 China BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 40 China BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 41 India BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 42 India BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 44 Australia BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 46 South Korea BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 48 Thailand BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 53 Brazil BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 55 Argentina BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 60 South Africa BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 64 UAE BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 66 Kuwait BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 BCG vaccine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 BCG vaccine market dynamics
  • Fig. 11 BCG vaccine market: Porter's five forces analysis
  • Fig. 12 BCG vaccine market: PESTLE analysis
  • Fig. 13 Product market, 2021 - 2033 (USD Million)
  • Fig. 14 Immune BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 15 Therapeutic BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 16 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 17 Public sector market, 2021 - 2033 (USD Million)
  • Fig. 18 Private sector market, 2021 - 2033 (USD Million)
  • Fig. 19 BCG vaccine market revenue, by region
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 North America BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. country dynamics
  • Fig. 23 U.S. BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 24 Canada country dynamics
  • Fig. 25 Canada BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 26 Mexico country dynamics
  • Fig. 27 Mexico BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 28 Europe BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 29 UK country dynamics
  • Fig. 30 UK BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 31 Germany country dynamics
  • Fig. 32 Germany BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 33 France country dynamics
  • Fig. 34 France BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 35 Italy country dynamics
  • Fig. 36 Italy BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 37 Spain country dynamics
  • Fig. 38 Spain BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 39 Norway country dynamics
  • Fig. 40 Norway BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 41 Sweden country dynamics
  • Fig. 42 Sweden BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 43 Denmark country dynamics
  • Fig. 44 Denmark BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia Pacific BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 46 Japan country dynamics
  • Fig. 47 Japan BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 48 China country dynamics
  • Fig. 49 China BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 50 India country dynamics
  • Fig. 51 India BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 52 Australia country dynamics
  • Fig. 53 Australia BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea country dynamics
  • Fig. 55 South Korea BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand country dynamics
  • Fig. 57 Thailand BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil country dynamics
  • Fig. 60 Brazil BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina country dynamics
  • Fig. 62 Argentina BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 63 MEA BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa country dynamics
  • Fig. 65 South Africa BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia country dynamics
  • Fig. 67 Saudi Arabia BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 68 UAE country dynamics
  • Fig. 69 UAE BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 70 Kuwait country dynamics
  • Fig. 71 Kuwait BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 72 Company categorization
  • Fig. 73 Company market position analysis
  • Fig. 74 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!